Cargando…

The SAMe-TT(2)R(2) Score Predicts Warfarin Control in an Australian Population with Atrial Fibrillation

Background: Warfarin requires regular monitoring with the time in therapeutic range (TTR), a common indicator of control and TTR > 70% is indicative of efficient anticoagulation. The SAMe-TT(2)R(2) (sex, age, medical history, treatment, tobacco use, race) model has been utilised as a predictor of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernaitis, Nijole, Clark, Gemma, Kohja, Sarah, Leong, Stephanie, Anoopkumar-Dukie, Shailendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616538/ https://www.ncbi.nlm.nih.gov/pubmed/31226834 http://dx.doi.org/10.3390/jcm8060882

Ejemplares similares

The Use of Fish Oil with Warfarin Does Not Significantly Affect either the International Normalised Ratio or Incidence of Adverse Events in Patients with Atrial Fibrillation and Deep Vein Thrombosis: A Retrospective Study
por: Pryce, Rebecca, et al.
Publicado: (2016)

Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
por: Bernaitis, Nijole, et al.
Publicado: (2018)

Protection against Radiotherapy-Induced Toxicity
por: Hall, Susan, et al.
Publicado: (2016)

Drivers of Radioresistance in Prostate Cancer
por: King, Liam, et al.
Publicado: (2022)

Use of the SAMe-TT(2)R(2) Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence
por: Chan, Pak Hei, et al.
Publicado: (2016)

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT(2)R(2) score
por: Methavigul, Komsing, et al.
Publicado: (2023)

Evaluation of the Validity of SAMe-TT(2)R(2) Score in a Cohort of Venous Thromboembolism Patients Treated With Warfarin
por: Alhmoud, Eman Nawash, et al.
Publicado: (2020)

SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?
por: Zhang, Yuqing, et al.
Publicado: (2021)

Effect of SAMe-TT(2)R(2) score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
por: Elewa, Hazem, et al.
Publicado: (2020)

Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study
por: King, Liam, et al.
Publicado: (2020)

Provision of externally accredited immunisation certification within an Australian Professional Pharmacy University programme: a survey of graduates on benefits and outcomes
por: Bernaitis, Nijole, et al.
Publicado: (2022)

Evaluation of ABC Bleeding Score and SAMe-TT2R2 Score on the Risk of Bleeding after Anticoagulation in Patients with Nonvalvular Atrial Fibrillation Complicated with Coronary Heart Disease
por: Du, Meiling, et al.
Publicado: (2022)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

The use of warfarin in veterans with atrial fibrillation
por: Bravata, Dawn M, et al.
Publicado: (2004)

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin
por: Methavigul, Komsing, et al.
Publicado: (2019)

Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia
por: Gospos, Jonathan, et al.
Publicado: (2019)

A Review of Black Salve: Cancer Specificity, Cure, and Cosmesis
por: Croaker, Andrew, et al.
Publicado: (2017)

Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses
por: Croaker, Andrew, et al.
Publicado: (2016)

Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis
por: van Miert, Jasper H. A., et al.
Publicado: (2018)

Anticoagulation Stability Depends on CHADS(2) Score and Hepatorenal Function in Warfarin-treated Patients, Including Those with Atrial Fibrillation
por: Odashiro, Keita, et al.
Publicado: (2017)

SAMe-TT(2)R(2) Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events
por: Pivatto Júnior, Fernando, et al.
Publicado: (2017)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Hansen, Carolina Malta, et al.
Publicado: (2012)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
por: Touchette, Daniel R., et al.
Publicado: (2008)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Rashid, Sana, et al.
Publicado: (2021)

Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour
por: Mallik, Sanchari Basu, et al.
Publicado: (2023)

Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation
por: Ono, Koji, et al.
Publicado: (2012)

RNA-binding protein signaling in adult neurogenesis
por: Chan, Jackie Ngai-Man, et al.
Publicado: (2022)

Statins Reduce Lipopolysaccharide-Induced Cytokine and Inflammatory Mediator Release in an In Vitro Model of Microglial-Like Cells
por: McFarland, A. J., et al.
Publicado: (2017)

Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic
por: Lee, Siew Ling, et al.
Publicado: (2021)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
por: de Padua Mansur, Antonio, et al.
Publicado: (2012)

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
por: Lee, Soyon, et al.
Publicado: (2012)

Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
por: Juma, Salima, et al.
Publicado: (2013)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
por: Choi, Jiyoon C, et al.
Publicado: (2014)

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation
por: Simon, Teresa A., et al.
Publicado: (2016)

Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
por: Kim, Hyunmee, et al.
Publicado: (2018)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban
por: Martins, Gabriela Lopes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cg263cnqnn1e1cl2qljakgsrn7